Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018 (2018), Article ID 6482958, 6 pages
https://doi.org/10.1155/2018/6482958
Research Article

Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice

Department of Diabetes Technology, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan

Correspondence should be addressed to Katsunori Nonogaki; pj.ca.ukohot.dem.crt@ustak

Received 23 September 2017; Revised 17 November 2017; Accepted 14 December 2017; Published 1 February 2018

Academic Editor: Toshiyasu Sasaoka

Copyright © 2018 Katsunori Nonogaki and Takao Kaji. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Nonogaki, A. M. Strack, M. F. Dallman, and L. H. Tecott, “Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene,” Nature Medicine, vol. 4, no. 10, pp. 1152–1156, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Nonogaki and T. Kaji, “The acute anorexic effect of liraglutide, a GLP-1 receptor agonist, does not require functional leptin receptor, serotonin, and hypothalamic POMC and CART activities in mice,” Diabetes Research and Clinical Practice, vol. 120, pp. 186–189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Anderberg, J. E. Richard, K. Eerola et al., “Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight,” Diabetes, vol. 66, no. 4, pp. 1062–1073, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Nonogaki and T. Kaji, “Hypothalamic orexin and pro-opiomelanocortin activities are essential for the anorexic effects of m-chlorophenylpiperazine in mice,” International Journal of Neuropsychopharmacology, vol. 13, no. 9, pp. 1261–1267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Liu, Y. Jiang, Y. Si, J. Y. Kim, Z. F. Chen, and Y. Rao, “Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice,” Nature, vol. 472, no. 7341, pp. 95–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Weng, S. Shen, Y. Tian et al., “Metabolomics approach reveals integrated metabolic network associated with serotonin deficiency,” Scientific Reports, vol. 5, no. 1, p. 11864, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Nonogaki, M. Suzuki, M. Sanuki, M. Wakameda, and T. Tamari, “The contribution of serotonin 5-HT2C and melanocortin-4 receptors to the satiety signaling of glucagon-like peptide 1 and liragultide, a glucagon-like peptide 1 receptor agonist, in mice,” Biochemical and Biophysical Research Communications, vol. 411, no. 2, pp. 445–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Fox, H. T. French, J. L. LaPorte, A. R. Blacler, and D. L. Murphy, “The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis,” Psychopharmacology, vol. 212, no. 1, pp. 13–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-M. Oh, J. Namkung, Y. Go et al., “Regulation of systemic energy homeostasis by serotonin in adipose tissues,” Nature Communications, vol. 6, article 6794, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Crane, R. Palanivel, E. P. Mottillo et al., “Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis,” Nature Medicine, vol. 21, no. 2, pp. 166–172, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. K. V. Savelieva, S. Zhao, V. M. Pogorelov et al., “Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants,” PLoS One, vol. 3, no. 10, article e3301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. V. K. Yadav, F. Oury, N. Suda et al., “Leptin regulation of bone mass, appetite and energy expenditure relies on its ability to inhibit serotonin synthesis in the brainstem,” Cell, vol. 138, no. 5, pp. 976–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Shemesh, A. Abdulla, F. Yang, S. C. Chua, J. E. Pessin, and H. Zong, “The antidepressant trans-2-phenylcyclopropylamine protects mice from high-fat diet-induced obesity,” PLoS One, vol. 9, no. 2, article e89199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nonogaki, K. Nozue, and Y. Oka, “Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice,” Biochemical and Biophysical Research Communications, vol. 351, no. 4, pp. 1078–1082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Grignaschi, F. Sironi, and R. Samanin, “Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor,” Brain Research, vol. 708, no. 1-2, pp. 173–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Martin-Gronert, C. J. Stocker, E. T. Wargent et al., “5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats,” Disease Models & Mechanisms, vol. 9, no. 4, pp. 401–412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Gray and B. L. Roth, “Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists,” Brain Research Bulletin, vol. 56, no. 5, pp. 441–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Beiroa, M. Imbernon, R. Gallego et al., “GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK,” Diabetes, vol. 63, no. 10, pp. 3346–3358, 2014. View at Publisher · View at Google Scholar · View at Scopus